pathway analysis
ingenuity pathway analysis
ingenuity pathway ingenuity pathways
ingenuity software
ingenuity pathways analysis
pathways analysis
   
  Home | Products & Services | Library | News & Events | Partners | About Us | Careers
 


Ingenuity CTO invited to participate in NIH-initiated workshop on biosecurity


YFG Powered by Ingenuity wins CIO 100 Award for Innovative Web Research Tool

 
 
PRESS RELEASES

Ingenuity Systems Announces New Distributor for South Korea

New IPA 8.0 Features Dynamic Reports and Weekly Content Updates

Gene Expression Workflow Leverages Genetic Systems and Genomic Assays from Life Technologies Corporation

 

“Our work is focused on developing new drug therapies for biodefense-related and emerging viral pathogens. IPA was the bridge between our high throughput siRNA screen and identification of effective drugs that blocked infection in culture and are showing great promise in our animal work. We expect that IPA will also be an important tool when analyzing results of our latest high throughput drug screens.”

– Robert Davey, PhD, Galveston National Laboratory,
University of Texas Medical Branch (UTMB)

See how IPA was used in this publication:

Identification of Novel Cellular Targets for Therapeutic Intervention Against Ebola Virus Infection by siRNA Screening

Drug Development Research 70 : 255–265 (2009) Andrey A. Kolokoltsov, Mohammad F. Saeed, Alexander N. Freiberg, Michael R. Holbrook, and Robert A. Davey.

» Link to Article Synopsis
» Search Publications

 
TRAINING  

Ingenuity offers free weekly training webinars for IPA.

» View Schedule

 
CONFERENCES
Molecular Medicine Tri-Conference
February 3-4, San Francisco, CA
Booth 307
Ingenuity Presentation: 9 am, Thursday 2/4, "Real Examples of Integrating Pathway Data" session
SOT Tox Expo
March 8-10, Salt Lake City, UT
Booth 1316
Ingenuity Presentation - time TBD
ABRF
March 20-23, Sacramento, CA
Booth 510